Biopharmaceutical Processing Equipment and Consumables Market to be Worth $75.72 Billion by 2031- Exclusive Report by Meticulous Research®

REDDING, Calif., Aug. 14, 2024 /PRNewswire/ -- According to a new market research report titled, 'Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Forecast to 2031,' published by Meticulous Research^®, the global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.

Download Sample Report Now- https://www.meticulousresearch.com/download-sample-report/cp_id=4200 

Biopharmaceutical processing involves the study of the discovery, development, and processing of complex medicines using living cells and organisms. Biopharmaceuticals include vaccines, blood and blood components, gene therapies, recombinant therapeutic proteins, and somatic cells.

This market's growth is primarily due to the rising government focus on biologics adoption, key players' focus on increasing manufacturing capacity for biopharmaceuticals, and the growing adoption of disposable bioprocessing equipment & consumables. Further potential for market expansion includes the transition to bioprocessing 4.0, the growing use of customized medications, and emerging economies.

Emerging Economies to Provide Growth Opportunities for the Players Operating in the Market

Market demand for consumables and equipment related to biopharmaceutical processing has been significantly influenced by developed economies, like the United States and Europe. The participants in this industry are progressively focusing on emerging economies that are still relatively underdeveloped, as these markets have comparatively stronger penetration. Growing demand for biopharmaceutical processing supplies and equipment, an aging population with infectious and chronic illnesses, rising costs for pharmaceutical R&D, the growing need for biologics, and rising disposable income all point to high growth potential in emerging nations in Asia and Latin America.

Get a Glimpse Inside: Request Sample Pages- https://www.meticulousresearch.com/request-sample-report/cp_id=4200 

The biopharmaceutical industry is expanding throughout China, India, and the member countries of the Association of Southeast Asian Nations (ASEAN) in the Asia-Pacific region, as well as Brazil and Mexico in Latin America. This growth is being fuelled by rising public & private funding for research & development as well as increasing contract research and manufacturing activities. The biopharmaceutical industries are being forced to outsource research, development, and manufacturing in order to save money and time due to the increasing demand for biopharmaceuticals and the mounting need to reduce the excessive cost of development. As a result, CDMOs in developing countries are expanding quickly and actively engaged in the creation and advancement of biopharmaceuticals.

This is attributed to growing investments in infrastructure and capacity development, low labor costs, improving adherence to global manufacturing standards, and increasing regulatory oversight.

The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

The global biopharmaceutical processing equipment and consumables market is segmented by product type into filtration systems, chromatography equipment and consumables, bioreactors, cell culture products, mixers/mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, and other consumables and accessories.

Have Specific Research Needs? Request a Customized Report- 
https://www.meticulousresearch.com/request-customization/cp_id=4200 

By product, in 2024, the filtration systems segment is estimated to account for the largest share, 22.3%, of the biopharmaceutical processing equipment and consumables market. Critical use of filtration in upstream, process development, and downstream bioprocessing processes and advancing filtration technologies to meet growing bioprocessing needs are the factors contributing to the largest share of the market.

By application, the market for biopharmaceutical processing equipment and consumables is divided by application into commercial bioproduction and research bioproduction. The commercial bioproduction segment is projected to experience the highest growth rate, with a CAGR of 10.1% from 2024 to 2031. This growth is driven by factors such as rising regulatory approvals for biologics, biosimilars, and bio-betters; an increase in biologic therapeutic agents aimed at addressing the COVID-19 pandemic; and upcoming patent expirations for biologics, all of which are expected to boost demand for bioprocessing equipment in the commercial production of biopharmaceuticals.

Chronic disease is treated with monoclonal antibodies, which are employed in biologics and biosimilars. The need for monoclonal antibodies rises in tandem with the incidence and severity of chronic illnesses. Pharmaceutical and biopharmaceutical businesses are strengthening their market share by producing antibodies through bioproduction in order to meet the increasing demand.

By end user, the biopharmaceutical processing equipment and consumables market is segmented into pharmaceutical and biopharmaceutical companies, academic & research institutes contract development and manufacturing organizations (CDMOs). The CDMOs segment is anticipated to grow at the highest CAGR during the forecast period. This growth is fuelled by the increasing trend of outsourcing biopharmaceutical manufacturing to bioprocessing hubs in countries like India, South Korea, and Singapore. Pharmaceutical and biopharmaceutical companies are increasingly outsourcing drug discovery and manufacturing to shorten drug development timelines, reduce costs, enhance R&D productivity, and improve operational flexibility, boosting their profit margins.

By geography, in 2024, Europe is projected to hold the largest share of 33.5% of the biopharmaceutical processing equipment and consumables market. Within Europe, Germany is expected to hold the largest market share. This prominent position is attributed to Germany's significant pharmaceutical export volumes, substantial government grants and funding for biotech and biopharmaceutical companies, and the expansion of biopharmaceutical companies' capacities to produce biologics-based drugs and therapeutics in response to growing market demand.

Browse In-depth Report Now- https://www.meticulousresearch.com/product/biopharmaceutical-processing-equipment-and-consumables-market-4200 

Scope of the Report:

Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type

• Filtration Systems
• Chromatography Equipment and Consumables
  • Chromatography Consumables
  • Chromatography Equipment
• Bioreactors
  • Reusable Bioreactors
  • Single-use Bioreactors
• Cell Culture Products
  • Cell Culture Media
    • Cell Culture Media, by Physical Form
      • Dry Powder Media
      • Liquid Media
    • Cell Culture Media, by Type
      • Off-the-Shelf Media
      • Custom Media
    • Cell Culture Media, by Source
      • Chemically Defined Media
      • Natural Media
  • Reagents and Supplements
  • Cell and Cell Lines
  • Serum
• Mixing Systems
• Bioprocessing Containers
• Sterilizers
• Centrifuges
• Incubators
• Shakers
• Biosafety Cabinets
• Other Equipment and Consumables
• Services

Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors

Global Biopharmaceutical Processing Equipment and Consumables Market, by Application

• Commercial Bioproduction
  • Vaccine Manufacturing
  • mAb Production
  • Recombinant Protein Production
  • Cell and Gene Therapy Production
• Research Bioproduction

Global Biopharmaceutical Processing Equipment and Consumables Market, by End User

• Pharmaceutical & Biopharmaceutical Companies
• Contract Development and Manufacturing Organizations (CDMOs)
• Academia & Research Institutes

Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Switzerland
  • Denmark
  • Ireland
  • Belgium
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East & Africa

Unlock Opportunities: Buy Now- https://www.meticulousresearch.com/Checkout/87973509 

Related Reports:

Pharmaceutical Processing and Packaging Equipment Market Size, Share, Forecast, & Trends Analysis by Formulation (Oral, Parenteral) Secondary Packaging (Cartoning, Labelling) End-of-Line Packaging (Palletizing, Case Packaging)—Global Forecast to 2031

Pharmaceutical Processing Equipment Market by Mode of Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages {Filtration Units}], Parenterals [SIP, CIP, Process Systems], Topicals [Agitators, Homogenizers, Colloid Mills])—Global Forecasts to 2029

Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography—Forecast to 2028

Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User—Global Forecast to 2030

Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), End User (Pharma, academic)—Global Forecast to 2029

About Meticulous Research^®

Meticulous Research^® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Content Source: https://www.meticulousresearch.com/pressrelease/117/biopharmaceutical-processing-equipment-and-consumables-market-2031 

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg